D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Comcast
CMCSA
|
+$354M |
| 2 |
Wells Fargo
WFC
|
+$274M |
| 3 |
IBM
IBM
|
+$266M |
| 4 |
Qualcomm
QCOM
|
+$257M |
| 5 |
Mondelez International
MDLZ
|
+$224M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$356M |
| 2 |
PayPal
PYPL
|
+$290M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$261M |
| 4 |
NVIDIA
NVDA
|
+$248M |
| 5 |
AABA
Altaba Inc
AABA
|
+$245M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.61% |
| 2 | Healthcare | 10.26% |
| 3 | Consumer Discretionary | 10.07% |
| 4 | Financials | 8.17% |
| 5 | Communication Services | 7.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1526
CALL
Dollar General
DG
$27.3B
| $3.9M | 0.01% |
48,100
| – | – |
|
1527
Pan American Silver
PAAS
$18.6B
| $3.9M | 0.01% |
228,584
+162,598
| +246% | +$2.8M |
|
1528
Kaiser Aluminum
KALU
$2.59B
| $3.89M | 0.01% |
37,720
-25,502
| -40% | -$2.46M |
|
|
GLDD
1529
DELISTED
Great Lakes Dredge & Dock
GLDD
| $3.88M | 0.01% |
800,456
+28,004
| +4% | +$117K |
|
1530
Citi Trends
CTRN
$543M
| $3.88M | 0.01% |
195,336
+6,554
| +3% | +$130K |
|
1531
Heron Therapeutics
HRTX
$86.8M
| $3.88M | 0.01% |
240,175
+182,875
| +319% | +$2.87M |
|
1532
Prospect Capital
PSEC
$1.12B
| $3.88M | 0.01% |
577,122
-21,525
| -4% | -$161K |
|
1533
Manchester United
MANU
$3.95B
| $3.88M | 0.01% |
215,254
-2,780
| -1% | -$46.9K |
|
|
CERN
1534
DELISTED
Cerner Corp
CERN
| $3.88M | 0.01% |
54,331
-722,060
| -93% | -$47.9M |
|
|
CCMP
1535
DELISTED
CMC Materials, Inc. Common Stock
CCMP
| $3.87M | 0.01% |
48,442
+29,339
| +154% | +$2.16M |
|
|
ATVI
1536
PUT
DELISTED
Activision Blizzard
ATVI
| $3.87M | 0.01% |
+60,000
| New | +$3.74M |
|
1537
CALL
Churchill Downs
CHDN
$6.12B
| $3.86M | 0.01% |
112,200
+43,800
| +64% | +$1.4M |
|
|
EXAS
1538
PUT
DELISTED
Exact Sciences
EXAS
| $3.85M | 0.01% |
81,800
+2,800
| +4% | +$113K |
|
1539
Sabra Healthcare REIT
SBRA
$5.63B
| $3.85M | 0.01% |
175,473
+153,638
| +704% | +$3.47M |
|
1540
PUT
Eli Lilly
LLY
$1.07T
| $3.85M | 0.01% |
45,000
| – | – |
|
1541
Xylem
XYL
$28.6B
| $3.85M | 0.01% |
61,450
-88,772
| -59% | -$5.31M |
|
1542
Rigel Pharmaceuticals
RIGL
$702M
| $3.84M | 0.01% |
151,120
+15,591
| +12% | +$379K |
|
1543
M/I Homes
MHO
$3.82B
| $3.83M | 0.01% |
143,389
+1,404
| +1% | +$36.4K |
|
1544
Aecom
ACM
$9.15B
| $3.82M | 0.01% |
+103,869
| New | +$3.41M |
|
|
CYOU
1545
DELISTED
Changyou.com Limited American Depositary Share
CYOU
| $3.81M | 0.01% |
96,261
-20,946
| -18% | -$844K |
|
1546
CALL
Medtronic
MDT
$109B
| $3.8M | 0.01% |
48,900
-90,200
| -65% | -$7.49M |
|
1547
CALL
United Airlines
UAL
$38.8B
| $3.79M | 0.01% |
62,300
-36,200
| -37% | -$2.41M |
|
1548
PUT
Littelfuse
LFUS
$9.95B
| $3.78M | 0.01% |
+19,300
| New | +$3.5M |
|
|
CMA
1549
CALL
DELISTED
Comerica
CMA
| $3.77M | 0.01% |
49,400
-2,100
| -4% | -$150K |
|
1550
ZTO Express
ZTO
$18.2B
| $3.77M | 0.01% |
268,339
+244,908
| +1,045% | +$3.53M |
|
Similar funds
D.E. Shaw & Co's Q3 2017 Portfolio in Review
As of Q3 2017, D.E. Shaw & Co held 3,794 positions worth $65.1B, up 7.7% from $60.5B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.
D.E. Shaw & Co's Q3 2017 filing shows 469 new, 1,367 increased, 1,237 reduced and 370 closed positions. Its largest new stake was Baker Hughes: 3,076,914 shares worth $113M. The largest sale was Gilead Sciences, an estimated $356M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- D.E. Shaw & Co's largest Q3 2017 buy was Baker Hughes: 3,076,914 shares worth $113M.
- D.E. Shaw & Co added most to Comcast in Q3 2017, an estimated $354M increase.
- D.E. Shaw & Co's biggest Q3 2017 reduction was Gilead Sciences, cutting an estimated $356M.
- D.E. Shaw & Co fully exited Mobileye N.V. in Q3 2017, selling an estimated $72.4M.
- D.E. Shaw & Co's ten largest holdings make up 9.6% of its $65.1B portfolio in Q3 2017.
- D.E. Shaw & Co opened 469 new positions and closed 370 in Q3 2017.
- D.E. Shaw & Co's portfolio value rose 7.7% quarter-over-quarter to $65.1B.
Based on D.E. Shaw & Co's 13F filing for Q3 2017, filed 14 Nov 2017.